MarketPeel
Insider Trading Intelligence
SB

Stephen F. Betz

CRNX
CHIEF SCIENTIFIC OFFICER · CRINETICS PHARMACEUTICALS, INC. · CIK 0001886575
FILING MIX · LIFETIME20%/80%
BUYS
15
SELLS
59
TOTAL VALUE
$9.26M
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
137,101
AVG SELL PX
$29.55
TRADE KIND
SHOWING 74 / 74
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
53 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Stephen F. Betz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d53+58.49%-1.13%-0.09%-1.04%-1.11%-1.46
14d53+56.60%-0.49%-0.14%-0.36%-2.54%-0.34
30d53+60.38%-2.14%-0.18%-1.96%-3.49%-1.36
60d53+52.83%-2.41%+1.09%-3.50%-4.17%-1.93
90d53+56.60%-4.81%+0.70%-5.52%-4.56%-2.92
180d53(2 pending)+62.75%-2.44%+1.90%-4.34%-2.44%-1.64
1y53(2 pending)+54.90%+4.04%+6.57%-2.53%-16.18%-0.47
2y53(10 pending)+9.30%+81.75%+29.02%+55.19%+44.46%5.66
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRNX · 137,101 shares · as of Mar 16, 2026
049,29998,598147,897197,19620222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 15 buys / 59 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,371$37.11$236.4K141,342Mar 16, 2026Mar 18, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,241$37.77$160.2K137,101Mar 16, 2026Mar 18, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,000147,713Feb 23, 2026Feb 25, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
47,00047,000Feb 23, 2026Feb 25, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
Chief Scientific Officer
18,000$1.91$34.4K117,713Dec 26, 2025Dec 29, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
18,00090,514Dec 26, 2025Dec 29, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
Chief Scientific Officer
71,525$1.91$136.6K180,551Jun 12, 2025Jun 16, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
Chief Scientific Officer
16,645$9.28$154.5K197,196Jun 12, 2025Jun 16, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
16,64558,198Jun 12, 2025Jun 16, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
71,525108,514Jun 12, 2025Jun 16, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
97,483$32.23$3.14M99,713Jun 12, 2025Jun 16, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
291$34.83$10.1K108,588Mar 19, 2025Mar 21, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,479$34.17$187.2K108,879Mar 19, 2025Mar 21, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
65,00065,000Feb 20, 2025Feb 24, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
43,000114,358Feb 20, 2025Feb 24, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
Chief Scientific Officer
2,331$1.91$4.5K71,358Dec 16, 2024Dec 18, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
2,331180,039Dec 16, 2024Dec 18, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,035$51.50$53.3K68,576Sep 10, 2024Sep 12, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$53.19$159.6K69,611Aug 26, 2024Aug 28, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$47.68$143.0K72,611Aug 12, 2024Aug 14, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$53.43$160.3K75,611Jul 25, 2024Jul 26, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$48.55$145.7K78,611Jul 10, 2024Jul 12, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$45.37$136.1K80,643Jun 25, 2024Jun 26, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$43.86$131.6K83,643Jun 10, 2024Jun 11, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$47.49$142.5K86,643May 28, 2024May 30, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$49.43$148.3K89,643May 10, 2024May 14, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,655$38.14$139.4K92,643Mar 18, 2024Mar 20, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
23,00096,298Mar 4, 2024Mar 6, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
87,00087,000Mar 4, 2024Mar 6, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$37.26$111.8K73,298Jan 25, 2024Jan 26, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$37.65$113.0K76,298Jan 10, 2024Jan 12, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$35.89$107.7K79,298Dec 26, 2023Dec 27, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$32.87$98.6K82,298Dec 11, 2023Dec 13, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$31.84$95.5K85,298Nov 27, 2023Nov 29, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
1,410$17.12$24.1K86,879Mar 16, 2023Mar 17, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
23,60088,289Mar 1, 2023Mar 3, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
110,000110,000Mar 1, 2023Mar 3, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$19.59$61.2K64,689Feb 1, 2023Feb 3, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
8,336$21.07$175.6K67,815Jan 25, 2023Jan 27, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$18.00$56.3K76,151Jan 17, 2023Jan 19, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$18.35$57.4K79,277Jan 3, 2023Jan 5, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$16.00$50.0K82,403Dec 15, 2022Dec 19, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$17.84$55.8K84,968Dec 1, 2022Dec 5, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$18.72$58.5K88,094Nov 15, 2022Nov 17, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$18.52$57.9K91,220Nov 1, 2022Nov 3, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$17.73$55.4K94,346Oct 17, 2022Oct 19, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$19.64$61.4K97,472Oct 3, 2022Oct 5, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
4,168$21.01$87.6K100,598Sep 15, 2022Sep 19, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
1,042$21.00$21.9K104,766Sep 7, 2022Sep 9, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,126$18.59$58.1K105,808Sep 1, 2022Sep 6, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
Chief Scientific Officer
1,336$11.02$14.7K108,934May 20, 2022Sep 6, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,247$20.10$65.3K107,598May 2, 2022May 4, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
5,664$25.81$146.2K110,845Apr 18, 2022Apr 21, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
9,000$23.97$215.8K116,509Apr 4, 2022Apr 6, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
4,164$21.80$90.8K125,509Apr 1, 2022Apr 1, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
4,164$21.06$87.7K129,673Mar 31, 2022Apr 1, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,123$18.94$59.1K133,837Mar 15, 2022Mar 17, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,123$19.73$61.6K136,960Mar 1, 2022Mar 2, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
77,00077,000Feb 28, 2022Mar 2, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,500140,083Feb 28, 2022Mar 2, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,123$18.64$58.2K123,583Feb 15, 2022Feb 17, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,123$18.79$58.7K126,706Feb 1, 2022Feb 3, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
4,168$23.29$97.1K128,875Jan 18, 2022Jan 20, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
7,168$28.02$200.8K133,043Jan 3, 2022Jan 6, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,000$27.95$83.9K140,211Dec 28, 2021Dec 30, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
5,668$24.14$136.8K143,211Dec 15, 2021Dec 17, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
5,668$27.38$155.2K148,879Dec 1, 2021Dec 3, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
1,500$27.97$42.0K154,547Nov 16, 2021Nov 17, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
5,668$26.75$151.6K156,047Nov 15, 2021Nov 17, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,900$28.42$110.8K161,715Nov 8, 2021Nov 9, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
12,600$27.95$352.2K165,615Nov 5, 2021Nov 9, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
5,668$24.79$140.5K178,215Nov 1, 2021Nov 3, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
3,000$24.00$72.0K183,883Oct 27, 2021Oct 28, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
Chief Scientific Officer
1,042$21.10$22.0K186,883Oct 21, 2021Oct 25, 2021View →
Other insiders · CRNX
Loading peer insiders…
About this filer
CIK 0001886575
ROLE
Chief Scientific Officer
PRIMARY
CRNX
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001886575DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback